Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2024 11:15 ET | Source: Upstream Bio, Inc.

Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference

Positive results from a Phase 1 dose ranging study of verekitug (UPB-101) in asthma presented at ATS 2024